All In Biotech

Drug Trial Radar · NCT07759362

Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of KN3835 vs Placebo in the Treatment of Flexible/Semi-Flexible Hammertoe

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 554 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

554

Planned (sponsor's estimate)

Start

Aug 11, 2026

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Sponsor type
Industry
First posted
Aug 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to assess the efficacy, safety, and tolerability of KN3835 compared to placebo in the treatment of flexible/semi-flexible HMT.

Conditions

  • Flexible Hammertoe
  • Semi-flexible Hammertoe

Interventions

  • KN3835Biological

    Participants will receive KN3835.

  • PlaceboOther

    Participants will receive placebo matching to KN3835.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Day 57 in Flexion Contracture as Measured by GoniometerTime frame: Baseline, Day 57

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • Keenova Site-010

    Tucson, Arizona · Recruiting

  • Keenova Site-009

    Corona, California · Recruiting

  • Keenova Site-005

    Encinitas, California · Recruiting

  • Keenova Site-015

    Los Angeles, California · Recruiting

  • Keenova Site-021

    Los Angeles, California · Recruiting

  • Keenova Site-022

    Los Angeles, California · Recruiting

  • Keenova Site-008

    Tarzana, California · Recruiting

  • Keenova Site-016

    Medley, Florida · Recruiting

  • Keenova Site-011

    Miami, Florida · Recruiting

  • Keenova Site-013

    Miami, Florida · Recruiting

  • Keenova Site-004

    Pinellas Park, Florida · Recruiting

  • Keenova Site-007

    Sweetwater, Florida · Recruiting

  • Keenova Site-023

    Springfield, Illinois · Recruiting

  • Keenova Site-020

    Overland Park, Kansas · Recruiting

  • Keenova Site-025

    Westwood, New Jersey · Recruiting

  • Keenova Site-003

    Bedford, Texas · Recruiting

  • Keenova Site-014

    Fort Worth, Texas · Recruiting

  • Keenova Site-019

    Georgetown, Texas · Recruiting

  • Keenova Site-017

    Houston, Texas · Recruiting

  • Keenova Site-001

    McAllen, Texas · Recruiting

  • Keenova Site-002

    McAllen, Texas · Recruiting

  • Keenova Site-024

    San Antonio, Texas · Recruiting

  • Keenova Site-018

    San Antonio, Texas · Recruiting

  • Keenova Site-012

    Bountiful, Utah · Recruiting

  • Keenova Site-006

    Salt Lake City, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.